Last updated
Gyre Therapeutics: Ma Activity
Gyre Therapeutics completed acquisition of Cullgen to create a U.S. and China-based fully integrated biopharmaceutical company
Source: GNW — Mergers & Acquisitions
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in the sector.
Market context: Against a Talent Market Index of 105.8 (Hot) (down 2.4 month-on-month), Asia is at steady (+0.5pts) on signal share.
Gyre Therapeutics: 1 signal in the last 90 days; 0.1% of MitchelLake's Asia signal flow.
More signals across Asia
Ma Activity · Asia
KKR →KKR is marketing nine commercial properties across China (Beijing apartments, Shanghai hotel on the Bund) for sale. Expects 50-60% of original purchase prices, indicating major divestment from Chinese real estate.
Ma Activity · Asia
Treasury Wine Estates →Treasury Wine Estates has halted Penfolds Bin 407 orders in China, suggesting potential market contraction or strategic portfolio review
Ma Activity · Asia
Logitech →Logitech's China distributor (Shanghai Baishide Electronics Company) was fined US$30,000 by Shanghai authorities for an offensive advertisement that likened consumers to dogs
Ma Activity · Asia
Western Digital →Western Digital is in renewed merger talks with Japan-based Kioxia, focusing on combining flash memory assets through a share-based deal or spin-off structure.
Ma Activity · Asia
Fairfax →Fairfax is an active bidder in the accelerated IDBI Bank stake sale process in India.
Ma Activity · Asia
WuXi AppTec →U.S. Department of Defense is presenting a case to designate WuXi AppTec as a Chinese military company, citing state ownership links and military research connections.
Intelligence powered by Autonodal ↗